Model
Edge
Dicerna Pharmaceuticals Inc
0001399529
Filing type
8-K
Filing date
Dec 27, 2021
Updated
Dec 28, 2021 ยท 2:28 AM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
Exhibits
EX-3.1
EX-3.1
EX-3.2
EX-3.2
EX-99.1
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events